tm
Seeing Is Believing
tm
Seeing Is Believing
AVIR is currently covered by 1 analysts with an average price target of $7.31. This is a potential upside of $3.81 (108.86%) from yesterday's end of day stock price of $3.5.
Atea Pharmaceuticals 's activity chart (see below) currently has 24 price targets and 17 ratings on display. The stock rating distribution of AVIR is 50% SELL and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 65% with an average time for these price targets to be met of 49 days.
Highest price target for AVIR is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 11-Apr-2025. First documented stock forecast 24-Nov-2020.
Currently out of the existing stock ratings of AVIR, 1 are a SELL (50%), 1 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6
$2.5 (71.43%)
$6.88
4 months 9 days ago
(11-Apr-2025)
7/10 (70%)
$3.29 (121.40%)
43
Sell
$8
2 years 10 days ago
(10-Aug-2023)
3/5 (60%)
$4.32 (117.39%)
55
What is AVIR (Atea Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on AVIR (Atea Pharmaceuticals )?
Which analyst is the currently most bullish on AVIR (Atea Pharmaceuticals )?
Which analyst is the currently most reserved on AVIR (Atea Pharmaceuticals )?
